Supernus Pharmaceuticals Inc

NASDAQ:SUPN   3:59:53 PM EDT
33.51
-0.47 (-1.38%)
Earnings Announcements

Supernus Announces Second Quarter 2022 Financial Results

Published: 08/04/2022 20:58 GMT
Supernus Pharmaceuticals Inc (SUPN) - Supernus Announces Second Quarter 2022 Financial Results.
Q2 2022 Total Revenues of $170.1 Million, a 20% Increase Compared to Q2 2021.
Qtrly Earnings per Share $0.14.
Sees 2022 Total Revenues in the Range of $640 Million - $680 Million.
Q2 Earnings per Share View $0.29 -- Refinitiv Ibes Data (analyst estimates).
Q2 Revenue View $164.2 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $172.14 Million
Adjusted EPS is expected to be $0.35

Next Quarter Revenue Guidance is expected to be $177.53 Million
Next Quarter EPS Guidance is expected to be $0.46

More details on our Analysts Page.